AKT1 and head and neck squamous cell carcinoma: Taken together, Gefitinib inhibition of EGFR led to subsequent inhibition of Akt, mTOR and ERK pathways, as well as abnormal up-regulation of IKK/NF-κB signalling in HNSCC cells.